Text Message Education for Heart Disease in HIV/AIDS
Trial Summary
What is the purpose of this trial?
The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Digital Educational Messaging for heart disease in HIV/AIDS?
Is text message-based health education safe for humans?
How is the treatment of Digital Educational Messaging for heart disease in HIV/AIDS unique?
Digital Educational Messaging is unique because it uses text messages to provide health education, which is a low-cost, instant, and widely accessible method to support behavior change and improve health literacy, unlike traditional treatments that may rely on in-person visits or medications.3471011
Research Team
Megan McLaughlin, MD, MPH
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for English-speaking adults over 40 years old who are living with HIV but do not have existing cardiovascular disease. Participants must own a smartphone and be willing to provide informed consent. Pregnant individuals cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive educational text messages about HIV and heart disease risk 3-5 times per week for up to 6 months
Follow-up
Participants are monitored for cardiovascular risk factors and health outcomes after the intervention
Treatment Details
Interventions
- Digital Educational Messaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator